Dr. B. Dean Nardis

Dr. B. Dean Nardis (DR. B. DEAN NARDIS ) is Doctors Optometrist Physician in Belleville, PA. The NPI Number for Dr. B. Dean Nardis is 1467563676.

The current location address for Dr. B. Dean Nardis is 4461 E. MAIN ST. Belleville, PA 17004 and the contact number is 7173296588 and fax number is . The mailing address for Dr. B. Dean Nardis is 344 HICKORY LN Belleville, PA 17004- 7173296588 (mailing address contact number - 7173296588).

Doctors of optometry (ODs) are the primary health care professionals for the eye. Optometrists examine, diagnose, treat, and manage diseases, injuries, and disorders of the visual system, the eye, and associated structures as well as identify related systemic conditions affecting the eye. An optometrist has completed pre-professional undergraduate education in a college or university and four years of professional education at a college of optometry, leading to the doctor of optometry (O.D.) degree. Some optometrists complete an optional residency in a specific area of practice. Optometrists are eye health care professionals state-licensed to diagnose and treat diseases and disorders of the eye and visual system.

What is the NPI Number for Dr. B. Dean Nardis ?

Answer: The NPI Number for Dr. B. Dean Nardis is 1467563676

Where is Dr. B. Dean Nardis located?

Answer: Dr. B. Dean Nardis is located at 4461 E. MAIN ST. Belleville, PA 17004.

What is the specialty for Dr. B. Dean Nardis ?

Answer: The Specialty of Dr. B. Dean Nardis is Doctors Optometrist Physician.

Are there any online reviews for Dr. B. Dean Nardis ?

Answer: Not yet!

Are there any other health care providers in Belleville, PA?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Optometry
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	46
Number of Standardized 30-Day Fills	87.966666667
Aggregate Cost Paid for All Claims	3616.01
Number of Day's Supply for All Claims	2504
Number of Medicare Beneficiaries	11
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	*
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	40
Aggregate Cost Paid for Generic Drugs	479.53
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	#
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	23
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	2926.33
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	23
Aggregate Cost Paid for Claims Filled by	689.68
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst	*
Number of Claims for Beneficiaries Covered by Low-Income Subsidy
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst	#
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy
by Low-Income Subsidy
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims	0
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	0
Aggregate Cost Paid for Antibiotic Drugs	0
Antibiotic Claims	0
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst	*
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	69.545454545
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White	11
Number of Black or African American	0
Number of Asian Pacific Islander	0
Number of Hispanic Beneficiaries	0
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not	0
Only Entitlement
Average Hierarchical Condition Category	0.8345454545